PreveCeutical Medical (FRA:18H) Change In Payables And Accrued Expense : €0.23 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is PreveCeutical Medical Change In Payables And Accrued Expense?

PreveCeutical Medical's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2024 was €-0.01 Mil. It means PreveCeutical Medical's Accounts Payable & Accrued Expense declined by €0.01 Mil from Sep. 2024 to Dec. 2024 .

PreveCeutical Medical's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was €0.23 Mil. It means PreveCeutical Medical's Accounts Payable & Accrued Expense increased by €0.23 Mil from Dec. 2023 to Dec. 2024 .

PreveCeutical Medical Change In Payables And Accrued Expense Historical Data

The historical data trend for PreveCeutical Medical's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical Change In Payables And Accrued Expense Chart

PreveCeutical Medical Annual Data

Trend

Jul15

Jul16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.31

0.38

0.36

0.23

PreveCeutical Medical Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															0.16	0.07	0.06	0.11	-0.01

PreveCeutical Medical Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.23 Mil.

PreveCeutical Medical Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PreveCeutical Medical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (FRA:18H) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

PRVCF:USA 18H:Germany PREV:Canada

Address

885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6

Website

https://www.preveceutical.com

PreveCeutical Medical Inc is a health sciences company. The principal business activity of the company is the development of options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical Headlines

No Headlines